PP 29
Polatuzumab based chemoimmunotherapy showing complete response in a patient of r/r diffuse large b-cell lymphoma
Akdeniz University Faculty of Medicine, Department of Hematology, Antalya, Turkey
Lido
2511
Vezesque se leu este artigo
1129
Total PDF
1382
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 20 | 6 | 26 |
| 2025 5 | 50 | 19 | 69 |
| 2025 4 | 40 | 17 | 57 |
| 2025 3 | 46 | 9 | 55 |
| 2025 2 | 33 | 14 | 47 |
| 2025 1 | 36 | 23 | 59 |
| 2024 12 | 27 | 13 | 40 |
| 2024 11 | 50 | 14 | 64 |
| 2024 10 | 34 | 27 | 61 |
| 2024 9 | 28 | 18 | 46 |
| 2024 8 | 38 | 20 | 58 |
| 2024 7 | 19 | 16 | 35 |
| 2024 6 | 20 | 18 | 38 |
| 2024 5 | 31 | 27 | 58 |
| 2024 4 | 17 | 13 | 30 |
| 2024 3 | 26 | 17 | 43 |
| 2024 2 | 19 | 20 | 39 |
| 2024 1 | 22 | 25 | 47 |
| 2023 12 | 23 | 29 | 52 |
| 2023 11 | 46 | 48 | 94 |
| 2023 10 | 31 | 27 | 58 |
| 2023 9 | 26 | 29 | 55 |
| 2023 8 | 17 | 10 | 27 |
| 2023 7 | 22 | 8 | 30 |
| 2023 6 | 19 | 18 | 37 |
| 2023 5 | 24 | 18 | 42 |
| 2023 4 | 20 | 4 | 24 |
| 2023 3 | 21 | 14 | 35 |
| 2023 2 | 19 | 9 | 28 |
| 2023 1 | 17 | 9 | 26 |
| 2022 12 | 19 | 17 | 36 |
| 2022 11 | 22 | 19 | 41 |
| 2022 10 | 22 | 17 | 39 |
| 2022 9 | 23 | 24 | 47 |
| 2022 8 | 22 | 19 | 41 |
| 2022 7 | 17 | 28 | 45 |
| 2022 6 | 22 | 17 | 39 |
| 2022 5 | 24 | 18 | 42 |
| 2022 4 | 19 | 21 | 40 |
| 2022 3 | 23 | 23 | 46 |
| 2022 2 | 47 | 22 | 69 |
| 2021 1 | 31 | 12 | 43 |
| 2021 12 | 15 | 25 | 40 |
| 2021 11 | 19 | 26 | 45 |
| 2021 10 | 33 | 31 | 64 |
| 2021 9 | 16 | 21 | 37 |
| 2021 8 | 20 | 33 | 53 |
| 2021 7 | 18 | 28 | 46 |
| 2021 6 | 15 | 21 | 36 |
| 2021 5 | 20 | 30 | 50 |
| 2021 4 | 19 | 53 | 72 |
| 2021 3 | 32 | 28 | 60 |
| 2021 2 | 12 | 18 | 30 |
| 2020 1 | 11 | 16 | 27 |
| 2020 12 | 10 | 12 | 22 |
| 2020 11 | 10 | 11 | 21 |
Mostrar tudo
